Polaris AI Pharma Dividends and Buybacks
Dividend criteria checks 1/6
Polaris AI Pharma is a dividend paying company with a current yield of 1.73%. Next payment date is on 9th April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
1.7%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 18.3% |
| Next dividend pay date | 09 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩100.000 |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Why EstechPharma Co., Ltd. (KOSDAQ:041910) Is A Top Dividend Stock
Apr 01
If You Had Bought EstechPharma's (KOSDAQ:041910) Shares Five Years Ago You Would Be Down 60%
Mar 06Declining Stock and Solid Fundamentals: Is The Market Wrong About EstechPharma Co., Ltd. (KOSDAQ:041910)?
Feb 07
We're Not So Sure You Should Rely on EstechPharma's (KOSDAQ:041910) Statutory Earnings
Jan 17Is EstechPharma Co., Ltd.'s (KOSDAQ:041910) 0.8% Dividend Worth Your Time?
Dec 22A Look At EstechPharma's (KOSDAQ:041910) Share Price Returns
Dec 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A041910 has been paying a dividend for less than 10 years.
Growing Dividend: A041910's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Polaris AI Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A041910) | 1.7% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A041910) (up to 3 years) | n/a |
Notable Dividend: A041910's dividend (1.73%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).
High Dividend: A041910's dividend (1.73%) is low compared to the top 25% of dividend payers in the KR market (3.91%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A041910's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate A041910's cash payout ratio to determine if its dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 14:56 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Polaris AI Pharma Corp. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Al Eum Lee | iM Securities |
| Sung Hwan Choi | Kyobo Securities Co., Ltd |
| Kidal Bae | Shinhan Investment Corp. |